Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies
- PMID: 39394990
- PMCID: PMC11486156
- DOI: 10.1080/19490976.2024.2415490
Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies
Erratum in
-
Correction.Gut Microbes. 2024 Jan-Dec;16(1):2418774. doi: 10.1080/19490976.2024.2418774. Epub 2024 Oct 25. Gut Microbes. 2024. PMID: 39450754 Free PMC article. No abstract available.
Abstract
The Gram-negative anaerobic species Fusobacterium nucleatum was originally described as a commensal organism from the human oral microbiome. However, it is now widely recognized as a key inflammophilic pathobiont associated with a wide variety of oral and extraoral diseases. Historically, F. nucleatum has been classified into four subspecies that have been generally considered as functionally interchangeable in their pathogenic potential. Recent studies have challenged this notion, as clinical data reveal a highly biased distribution of F. nucleatum subspecies within disease sites of both inflammatory oral diseases and various malignancies. This review details the historical basis for the F. nucleatum subspecies designations and summarizes our current understanding of the similarities and distinctions between these organisms to provide important context for future clinical and laboratory studies of F. nucleatum.
Keywords: Fusobacterium nucleatum; abscess; colorectal cancer; inflammophilic; microbiome; oncobacterium; periodontitis; subspecies.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures


Similar articles
-
Stratification of Fusobacterium nucleatum by local health status in the oral cavity defines its subspecies disease association.Cell Host Microbe. 2024 Apr 10;32(4):479-488.e4. doi: 10.1016/j.chom.2024.02.010. Epub 2024 Mar 12. Cell Host Microbe. 2024. PMID: 38479393 Free PMC article.
-
The prevalence of Fusobacterium nucleatum subspecies in the oral cavity stratifies by local health status.bioRxiv [Preprint]. 2023 Oct 26:2023.10.25.563997. doi: 10.1101/2023.10.25.563997. bioRxiv. 2023. Update in: Cell Host Microbe. 2024 Apr 10;32(4):479-488.e4. doi: 10.1016/j.chom.2024.02.010. PMID: 37961321 Free PMC article. Updated. Preprint.
-
Fusobacterium nucleatum - Friend or foe?J Inorg Biochem. 2021 Nov;224:111586. doi: 10.1016/j.jinorgbio.2021.111586. Epub 2021 Aug 18. J Inorg Biochem. 2021. PMID: 34425476 Review.
-
The role of Fusobacterium nucleatum in cancer and its implications for clinical applications.Mol Oral Microbiol. 2024 Dec;39(6):417-432. doi: 10.1111/omi.12475. Epub 2024 Jul 11. Mol Oral Microbiol. 2024. PMID: 38988217 Review.
-
Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer.NPJ Biofilms Microbiomes. 2025 May 20;11(1):81. doi: 10.1038/s41522-025-00717-7. NPJ Biofilms Microbiomes. 2025. PMID: 40394001 Free PMC article.
Cited by
-
Addressing controversy in Fusobacterium nomenclature: what exactly does "F. nucleatum" refer to?Gut Microbes. 2025 Dec;17(1):2514797. doi: 10.1080/19490976.2025.2514797. Epub 2025 Jun 4. Gut Microbes. 2025. PMID: 40464118 Free PMC article.
-
Microbial manipulators: Fusobacterium nucleatum modulates the tumor immune microenvironment in colorectal cancer.J Oral Microbiol. 2025 Aug 5;17(1):2544169. doi: 10.1080/20002297.2025.2544169. eCollection 2025. J Oral Microbiol. 2025. PMID: 40771747 Free PMC article. Review.
-
Exploring the Role of Cellular Interactions in the Colorectal Cancer Microenvironment.J Immunol Res. 2025 Apr 11;2025:4109934. doi: 10.1155/jimr/4109934. eCollection 2025. J Immunol Res. 2025. PMID: 40255905 Free PMC article. Review.
-
Establishment and improvement of genetic manipulation tools for Fusobacterium nucleatum.Eng Microbiol. 2025 Feb 8;5(1):100192. doi: 10.1016/j.engmic.2025.100192. eCollection 2025 Mar. Eng Microbiol. 2025. PMID: 40538714 Free PMC article. Review.
References
-
- Borozan I, Zaidi SH, Harrison TA, Phipps AI, Zheng J, Lee S, Trinh QM, Steinfelder RS, Adams J, Banbury BL, et al. Molecular and pathology features of colorectal tumors and patient outcomes are associated with Fusobacterium nucleatum and its subspecies animalis. Cancer Epidemiol Biomarker Prev. 2022;31(1):210–220. doi:10.1158/1055-9965.EPI-21-0463. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases